Financial Statements · Financial Reporting
TRIZLEX BIOPHARMA OÜ
Official identifier 11220756Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 29 Jun 2026
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 1,423,742 |
| Balance sheet | Cash and cash equivalents | 36,358 |
| Balance sheet | Current assets | 133,291 |
| Balance sheet | Current liabilities | 13,346 |
| Balance sheet | Equity | 1,373,696 |
| Balance sheet | Share capital at nominal value | 2,556 |
| Balance sheet | Non-current assets | 1,290,451 |
| Balance sheet | Non-current liabilities | 36,700 |
| Balance sheet | Retained earnings (loss) from previous periods | 470,895 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | -71,487 |
| Income statement scheme 1 | Revenue | 1,288,202 |
| Income statement scheme 1 | Annual period profit / loss | 900,245 |
| Income statement scheme 1 | Operating profit (loss) | 824,080 |
| Income statement scheme 1 | Profit (loss) before income tax | 900,245 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 470,895 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 51,743 |
Linked company
Company: TRIZLEX BIOPHARMA OÜ